OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

FRESEN.MED.CARE KGAA O.N./  DE0005785802  /

Xetra
3/31/2023  5:37:15 PM Chg. +0.240 Volume Bid3/31/2023 Ask5:37:51 PM Market Capitalization Dividend Y. P/E Ratio
39.100EUR +0.62% 1.4 mill.
Turnover: 54.68 mill.		 -Bid Size: - -Ask Size: - 11.37 bill.EUR 3.48% 11.72

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Carla Kriwet (ab 1.01.2023)
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 19 | 5/9/2023 Interim Report 1st Quarter/3 Months
CW 20 | 5/16/2023 General Shareholder Meeting
CW 31 | 8/2/2023 Interim Report 2nd Quarter/6 Months
CW 44 | 11/2/2023 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
 44.95%
Fresenius SE & Co. KGaA
 
 32.00%
Thornburg Investment Management Inc.
 
 4.96%
BlackRock, Inc.
 
 3.16%
Richard Pzena
 
 3.01%
Artisan Partners Asset Management Inc.
 
 2.99%
Harris Associates L.P.
 
 2.98%
FIL Limited
 
 2.98%
Norges Bank
 
 2.97%